HQY
HealthEquity, Inc.
HealthEquity, Inc. insider trading
HealthEquity, Inc. files with the SEC as a Services-Business Services, NEC company headquartered in Draper, UT. Every time one of its executives or directors buys or sells the stock, the filing appears here the moment it reaches the SEC — with grants and option exercises set apart from the trades that cost the insider their own money.
From SEC filings
Recent HQY insider transactions
4 insiders traded HQY on the open market between May 28, 2026 and Aug 25, 2026 — 7 sales worth $2.4M, of which every one was pre-scheduled under a 10b5-1 plan.
- Bought
- —
- Sold
- $2.4M
- Net
- −$2.4M
- Insiders
- 4
7 of 7 on a 10b5-1 plan
Dillon Adrian T10b5-1
Director
−$658.2K
Aug 25, 2026
6,300 sh · $104.47
Dillon Adrian T10b5-1
Director
−$140.2K
Aug 25, 2026
1,332 sh · $105.26
Fiore Michael Henry10b5-1
EVP, Chief Commercial Officer
−$223.6K
Jul 10, 2026
2,354 sh · $95.00
Fiore Michael Henry10b5-1
EVP, Chief Commercial Officer
−$234.7K
Jul 02, 2026
2,470 sh · $95.00
Fiore Michael Henry10b5-1
EVP, Chief Commercial Officer
−$298.5K
May 29, 2026
3,142 sh · $95.00
Wellborn Gayle Furgurson10b5-1
Director
−$219.5K
May 28, 2026
2,439 sh · $90.00
Ladd Delano10b5-1
EVP, General Counsel
−$675K
May 28, 2026
7,500 sh · $90.00
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Aug 25, 2026 | Dillon Adrian T10b5-1Director | 6,300 | $104.47 | −$658.2K |
| Aug 25, 2026 | Dillon Adrian T10b5-1Director | 1,332 | $105.26 | −$140.2K |
| Jul 10, 2026 | Fiore Michael Henry10b5-1EVP, Chief Commercial Officer | 2,354 | $95.00 | −$223.6K |
| Jul 02, 2026 | Fiore Michael Henry10b5-1EVP, Chief Commercial Officer | 2,470 | $95.00 | −$234.7K |
| May 29, 2026 | Fiore Michael Henry10b5-1EVP, Chief Commercial Officer | 3,142 | $95.00 | −$298.5K |
| May 28, 2026 | Wellborn Gayle Furgurson10b5-1Director | 2,439 | $90.00 | −$219.5K |
| May 28, 2026 | Ladd Delano10b5-1EVP, General Counsel | 7,500 | $90.00 | −$675K |
SEC Form 4 data, Q3 2024 to Q2 2026
HQY insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 11 insiders traded HQY on the open market: 0 purchases and 55 sales worth $52.1M, 28 of the sales pre-scheduled under a 10b5-1 plan. In the last four quarters alone: 0 purchases and 15 sales ($4.3M), by 5 insiders.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | — | −$1.2M3 sales · all on a plan | |
| Q1 2026 | — | — | |
| Q4 2025 | — | −$2.1M6 sales · 3 on a plan | |
| Q3 2025 | — | −$1.1M6 sales · 3 on a plan | |
| Q2 2025 | — | −$35.1M15 sales · 4 on a plan | |
| Q1 2025 | — | −$639.9K2 sales · all on a plan | |
| Q4 2024 | — | −$4.9M13 sales · 7 on a plan | |
| Q3 2024 | — | −$7.1M10 sales · 6 on a plan |
- Largest sale
- −$7M of HQY by Kessler Jon (Former Director) on Jun 06, 2025.
Open-market transactions through Jun 30, 2026most recent first
Ladd Delano10b5-1
EVP, General Counsel
−$142.1K
Dec 19, 2025
1,500 sh · $94.72
Rosner Elimelech
EVP, Chief Technology Officer
−$1M
Dec 18, 2025
10,959 sh · $95.45
Wellborn Gayle Furgurson
Director
−$425.4K
Dec 12, 2025
4,339 sh · $98.03
Ladd Delano10b5-1
EVP, General Counsel
−$156.8K
Nov 20, 2025
1,500 sh · $104.56
Ladd Delano10b5-1
EVP, General Counsel
−$138.1K
Oct 20, 2025
1,500 sh · $92.07
Fiore Michael Henry
EVP, Chief Commercial Officer
−$157.1K
Oct 07, 2025
1,781 sh · $88.21
Ladd Delano10b5-1
EVP, General Counsel
−$469.6K
Sep 19, 2025
5,000 sh · $93.91
Ladd Delano10b5-1
EVP, General Counsel
−$92.3K
Sep 19, 2025
971 sh · $95.06
Ladd Delano10b5-1
EVP, General Counsel
−$2.8K
Sep 19, 2025
29 sh · $95.70
Dilsaver Evelyn S
Director
−$322.9K
Sep 05, 2025
3,461 sh · $93.30
Fiore Michael Henry
EVP, Chief Commercial Officer
−$111K
Jul 07, 2025
1,094 sh · $101.50
Fiore Michael Henry
EVP, Chief Commercial Officer
−$71.5K
Jul 07, 2025
700 sh · $102.09
Rosner Elimelech
EVP, Chief Technology Officer
−$1.4M
Jun 09, 2025
13,000 sh · $111.37
Kessler Jon
Former Director
−$7M
Jun 06, 2025
62,827 sh · $111.84
Rosner Elimelech
EVP, Chief Technology Officer
−$6.5M
Jun 06, 2025
58,000 sh · $112.56
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Dec 19, 2025 | Ladd Delano10b5-1EVP, General Counsel | 1,500 | $94.72 | −$142.1K |
| Dec 18, 2025 | Rosner ElimelechEVP, Chief Technology Officer | 10,959 | $95.45 | −$1M |
| Dec 12, 2025 | Wellborn Gayle FurgursonDirector | 4,339 | $98.03 | −$425.4K |
| Nov 20, 2025 | Ladd Delano10b5-1EVP, General Counsel | 1,500 | $104.56 | −$156.8K |
| Oct 20, 2025 | Ladd Delano10b5-1EVP, General Counsel | 1,500 | $92.07 | −$138.1K |
| Oct 07, 2025 | Fiore Michael HenryEVP, Chief Commercial Officer | 1,781 | $88.21 | −$157.1K |
| Sep 19, 2025 | Ladd Delano10b5-1EVP, General Counsel | 5,000 | $93.91 | −$469.6K |
| Sep 19, 2025 | Ladd Delano10b5-1EVP, General Counsel | 971 | $95.06 | −$92.3K |
| Sep 19, 2025 | Ladd Delano10b5-1EVP, General Counsel | 29 | $95.70 | −$2.8K |
| Sep 05, 2025 | Dilsaver Evelyn SDirector | 3,461 | $93.30 | −$322.9K |
| Jul 07, 2025 | Fiore Michael HenryEVP, Chief Commercial Officer | 1,094 | $101.50 | −$111K |
| Jul 07, 2025 | Fiore Michael HenryEVP, Chief Commercial Officer | 700 | $102.09 | −$71.5K |
| Jun 09, 2025 | Rosner ElimelechEVP, Chief Technology Officer | 13,000 | $111.37 | −$1.4M |
| Jun 06, 2025 | Kessler JonFormer Director | 62,827 | $111.84 | −$7M |
| Jun 06, 2025 | Rosner ElimelechEVP, Chief Technology Officer | 58,000 | $112.56 | −$6.5M |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
HealthEquity, Inc. company record
- SEC industry classification
- Services-Business Services, NEC
- Headquarters
- Draper, UT
- Incorporated in
- DE
- Listed on
- Nasdaq
- SEC Central Index Key
- 0001428336
Sourced from this company's own SEC submissions record. The industry label is SEC's Standard Industrial Classification, which is more specific than the Health Care sector shown above.
After insiders bought HQY
What the stock actually did in the 90 days following each open-market purchase
Don't check HQY — let it ping you
Get told the moment an insider moves on HQY
Pro watches HealthEquity, Inc. for you and sends a Telegram ping within moments of a Form 4 clearing EDGAR — a C-suite open-market buy, a cluster, a 10b5-1 regime break — long before it reaches the press. Add HQY to a watchlist, see each mover's benchmark-measured track record and which legendary funds hold it, and read the full filing history instead of the last 72 hours.
The live dashboard is free to open. Alerts, watchlists, full filing history and each mover's benchmark-measured track record are Pro. Monitoring, not advice.
How to read HQY insider activity
- Open-market purchase (code P)
- An insider spending their own money at market price. This is the only buy code that reliably carries signal — it is a decision, not compensation.
- Grants and option exercises (codes A, M)
- Scheduled compensation. Most "insider buying" headlines are really this, which is why InsiderPulse weights it at a fraction of a real purchase.
- Cluster buy
- Two or more different insiders buying on the open market in the same window. One executive buying can mean anything; three is much harder to explain away.
Other Health Care tickers
Questions
- Are HQY insiders buying or selling?
- Between May 28, 2026 and Aug 25, 2026, 4 HealthEquity, Inc. insiders made no open-market purchases and 7 sales worth $2.4M, a net sale of $2.4M. 7 of the sales were pre-scheduled under a Rule 10b5-1 plan.
- How much HQY stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 11 HealthEquity, Inc. insiders made no open-market purchases and 55 sales worth $52.1M. 28 of the sales were pre-scheduled under a Rule 10b5-1 plan. In the four quarters to Jun 30, 2026: no purchases and 15 sales ($4.3M). The largest sale was Kessler Jon selling $7M on Jun 06, 2025.
- What was the largest recent HQY insider trade?
- Ladd Delano (EVP, General Counsel) sold $675K of HQY stock on May 28, 2026 at about $90.00 a share, under a pre-scheduled 10b5-1 plan.
- When did an insider last buy HQY shares?
- No open-market purchase by a HealthEquity, Inc. insider appears in the filings from May 28, 2026 to Aug 25, 2026 — every recorded open-market transaction in that period was a sale.
- Where does HQY insider trading data come from?
- From the Form 4 filings HealthEquity, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.